The Food and Drug Administration is expected this week to allow the overdose-reversal medication to be sold without a prescription, a step toward making it a common emergency tool.
BY JAN HOFFMAN | NYTimes Health | Disclosure
from Blogger https://ift.tt/Rk6ID3Y
via SEO Services
Co-founder and Managing Director at ARCHES, I am passionate about helping people increase their potential and showing them better ways to communicate and interact. Particularly interested in promoting sustainable development and inclusive growth, I am involved in the innovation dialogue with policy makers, and industrial and academic actors on the European scene and beyond.